European Association of Urology (EAU)Ovjeren akaunt

@Uroweb

We are: 18,000+ urologists. We do: Numerous scientific meetings, CME accreditation, scientific publications, research, awareness and more.

Vrijeme pridruživanja: veljača 2010.

Tweetovi

Blokirali ste korisnika/cu @Uroweb

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Uroweb

  1. proslijedio/la je Tweet
    prije 2 sata

    Today, on , I will be participating in the discussion on the . Early detection has to be included in 's Beating Cancer Plan.

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    prije 3 sata

    🔊Cancer-related complications and comorbidities are serious & often fatal yet still neglected in policy & research! Today on we are reshaping the face of cancer in 🇪🇺 We call for an integrated approach!➡️

    , , i još njih 6
    Poništi
  3. 3 urological cancers are among the top 10 most common cancers in Europe: Prostate, Bladder and Kidney. Every person matters. Every action counts. That is why we constantly update the EAUguidelines. ▶️

    Poništi
  4. proslijedio/la je Tweet

    “When I was a girl, my little sister died of cancer. I remember the utter helplessness of my parents. Every one of us has a similar story – or knows someone who has.” Tomorrow will open the event:

    Poništi
  5. proslijedio/la je Tweet

    Every person matters. Every action counts. This on 4 February, who are you and what will you do?

    Poništi
  6. proslijedio/la je Tweet
    2. velj
    Poništi
  7. proslijedio/la je Tweet
    3. velj

    Promising symposium on prostatecancer research

    Poništi
  8. Announcing the new date for the masterclass on BPO 👇

    Poništi
  9. proslijedio/la je Tweet

    When performing a RIRS, with which hand do you hold the flex ureteroscope? I'm worried regarding ergonomic issues...

    Poništi
  10. Assess the response to testosterone treatment at 3, 6 and 12 months after the onset, and thereafter annuall.

    Poništi
  11. proslijedio/la je Tweet
    1. velj

    BLADDER ART (NCT03333356) phase II trial in the treatment of MIBC patients with adjuvant radiotherapy is enrolling. To learn more, visit the protocol at clinical trial website.

    Poništi
  12. proslijedio/la je Tweet
    2. velj

    Male patients with urinary symptoms - please take this short survey and tell us your views....

    Poništi
  13. proslijedio/la je Tweet
    2. velj

    always working!!! Even on sundays!!! Just for being released on time and help all of us with our patients management!!

    Poništi
  14. Showcase your best scientific work at the meeting! Submit your abstract here ▶️ before the deadline of 01 April.

    Poništi
  15. proslijedio/la je Tweet
    1. velj

    February 2020 Issue The Complex and Nuanced Care for Early-stage Testicular Cancer: Lessons from the European Association of Urology and American Urological Association Testis Cancer Guidelines

    Poništi
  16. proslijedio/la je Tweet

    Proposed surveillance schedule following treatment for RCC, taking into account patient risk profile and treatment efficacy.

    Poništi
  17. proslijedio/la je Tweet
    31. sij
    Poništi
  18. proslijedio/la je Tweet
    31. sij

    Our study is causing some excitement. We’ve been asked to present findings at a headline session at the congress in March. Read more and download early findings

    Poništi
  19. proslijedio/la je Tweet

    Of Mice & Men: This top scientist thought he knew a lot about cancer. Then he got it. Rob Ramsey, & his colleague & surgeon , of join me on science, knowledge, vulnerability on

    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    30. sij

    📣 –ESMO consensus statements on the management of advanced and variant - an international collaborative multi-stakeholder effort 👉

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·